Gradientech starts US 510(k) study for QuickMIC® at clinical sites
Following successful pre-clinical evaluation studies of the QuickMIC system in the US last year, and with a breakthrough device designation ...
Read moreFollowing successful pre-clinical evaluation studies of the QuickMIC system in the US last year, and with a breakthrough device designation ...
Read moreAccording to the “AstraZeneca's Impact on Türkiye” Report, which reveals AstraZeneca's impact on the pharmaceutical industry and our country over ...
Read more